Apple Watch Hypertension Detection Coming Next Week After FDA Nod

Apple said that the hypertension detection system for the smart watch will come next week after receiving permission from the US Food and Pharmaceutical Administration on Thursday.

Apple’s latest product launch event in early September, the feature announced in the US, Hong Kong and the European Union, including 150 countries and regions will be presented. The company said that he had previously expected approval from FDA and other regulators.

According to Apple, the vehicle will use data from Apple Watch’s optical heart sensor to analyze how a user reacts to heartbeat for 30 days. If any chronic hypertension symptom or high blood pressure is identified and the user is informed if it is encouraged to share the results with a medical provider.

The vehicle will be available in the Apple Watch Series 9, Series 10, Serial 11, Ultra 2 and Ultra 3.

The update comes as Apple continues to expand health proposals in the midst of increasing competition from other technology companies, including Garmin, Samsung and Oura Health Oy.

Apple said that the new hypertension feature was developed with advanced machine learning and training data collected from a handful of studies with more than 100,000 participants.

Approximately 1.3 billion adults worldwide are affected by hypertension, which is the primary risk factor for stroke, heart attack and kidney disease, which can be replaced by lifestyle and medical interventions.

Over the years, consumer hardware manufacturers add more sophisticated health monitoring tools to fitness bands and smart watches and often blur lines between a wearable gadget and medical device.

WHOOP INC., a manufacturer of fitness bands without screen, actively pushes the requests to disable their blood pressure monitoring tool. The FDA said that the new WHOOP MG, which is short for the medical class, works as a medical device, but did not have a certificate for blood pressure monitoring.